| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ICPT | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -$720K | -37.9K | -100% | $19.00 | 0 | Nov 8, 2023 | Direct | F1 |
| transaction | ICPT | Common Stock | Disposition pursuant to a tender of shares in a change of control transaction | -$12.2M | -641K | -100% | $19.00 | 0 | Nov 8, 2023 | See footnote | F1, F2 |
| transaction | ICPT | Common Stock | Disposed to Issuer | -$154K | -8.11K | -100% | $19.00 | 0 | Nov 8, 2023 | Direct | F3, F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ICPT | Option to Purchase Common Stock | Disposed to Issuer | -12.1K | -100% | 0 | Nov 8, 2023 | Common Stock | 12.1K | $17.08 | Direct | F5 | ||
| transaction | ICPT | Option to Purchase Common Stock | Disposed to Issuer | -12.8K | -100% | 0 | Nov 8, 2023 | Common Stock | 12.8K | $16.82 | Direct | F5 | ||
| transaction | ICPT | Option to Purchase Common Stock | Disposed to Issuer | -12.5K | -100% | 0 | Nov 8, 2023 | Common Stock | 12.5K | $9.17 | Direct | F5 | ||
| transaction | ICPT | Option to Purchase Common Stock | Disposed to Issuer | -275 | -100% | 0 | Nov 8, 2023 | Common Stock | 275 | $210.36 | Direct | F6 | ||
| transaction | ICPT | Option to Purchase Common Stock | Disposed to Issuer | -1.75K | -100% | 0 | Nov 8, 2023 | Common Stock | 1.75K | $183.62 | Direct | F6 | ||
| transaction | ICPT | Option to Purchase Common Stock | Disposed to Issuer | -1.6K | -100% | 0 | Nov 8, 2023 | Common Stock | 1.6K | $145.22 | Direct | F6 | ||
| transaction | ICPT | Option to Purchase Common Stock | Disposed to Issuer | -2.04K | -100% | 0 | Nov 8, 2023 | Common Stock | 2.04K | $122.01 | Direct | F6 | ||
| transaction | ICPT | Option to Purchase Common Stock | Disposed to Issuer | -2.75K | -100% | 0 | Nov 8, 2023 | Common Stock | 2.75K | $85.12 | Direct | F6 | ||
| transaction | ICPT | Option to Purchase Common Stock | Disposed to Issuer | -2.17K | -100% | 0 | Nov 8, 2023 | Common Stock | 2.17K | $82.25 | Direct | F6 | ||
| transaction | ICPT | Option to Purchase Common Stock | Disposed to Issuer | -2.97K | -100% | 0 | Nov 8, 2023 | Common Stock | 2.97K | $72.74 | Direct | F6 |
Srinivas Akkaraju is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
| Id | Content |
|---|---|
| F1 | This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger (the "Merger Agreement"), dated as of September 26, 2023, among the Issuer, Alfasigma S.p.A. ("Alfasigma"), and Interstellar Acquisition Inc., a wholly owned subsidiary of Alfasigma ("Purchaser"), pursuant to which Purchaser completed a tender offer for shares of common stock of the Issuer ("Company Common Stock") and thereafter merged with and into the Issuer, effective as of November 8, 2023 (such date and time of such merger, the "Effective Time"). At the Effective Time, each issued and outstanding share of Company Common Stock was cancelled and converted into the right to receive $19.00 in cash (the "Offer Price") without interest and subject to applicable withholding taxes. |
| F2 | Shares held by Samsara BioCapital, L.P. ("Samsara BioCapital"). The Reporting Person is a managing member of Samsara BioCapital GP, LLC, the general partner of Samsara BioCapital. The Reporting Person disclaims beneficial ownership of these shares except to the extent of the Reporting Person's pecuniary interest therein. |
| F3 | Represents restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represented a contingent right to receive one share of Company Common Stock upon vesting of the RSU. |
| F4 | Pursuant to the Merger Agreement, at the Effective Time, each RSU that was outstanding as of immediately prior to the Effective Time was cancelled and converted into the contingent right to receive a cash payment (without interest and subject to any applicable tax withholding) equal to (A) the Offer Price, multiplied by (B) the number of shares of Company Common Stock subject to such RSU. Such payment right will vest and become payable in accordance with vesting schedule (including any vesting acceleration provisions) that applied to the corresponding portion of the applicable RSUs immediately prior to the Effective Time. |
| F5 | Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was less than the Offer Price, was cancelled and converted into the right to receive a cash payment (without interest, and less any applicable withholding taxes) equal to (A) the excess of (x) the Offer Price over (y) the exercise price payable per share of Company Common Stock under such option, multiplied by (B) the total number of shares of Company Common Stock subject to such option immediately prior to the Effective Time. |
| F6 | Pursuant to the Merger Agreement, each option to purchase shares of Company Common Stock that was outstanding and unexercised as of immediately prior to the Effective Time, whether or not vested, with a per share exercise price that was equal to or greater than the Offer Price was cancelled with no consideration payable in respect thereof. |